Outcome

The study demonstrates that Hyperbaric Oxygen Therapy (HBOT) significantly improves symptoms and cognitive functions in individuals with persistent post-concussion syndrome (PPCS) resulting from mild traumatic brain injury (mTBI).

Introduction

Persistent postconcussion syndrome (PPCS) following a mild traumatic brain injury (mTBI) represents a significant challenge for both civilians and military personnel often resulting in enduring symptoms and limited treatment options. This study investigates the potential benefits of hyperbaric oxygen therapy (HBOT) for individuals suffering from PPCS. Over an 8-week period 63 participants were divided into two groups: one receiving 40 sessions of HBOT at 150 kPa for 60 minutes each and a control group that initially received no treatment. Remarkable improvements were observed in the HBOT group across multiple measures including neurobehavioral symptoms memory cognitive function depression anxiety PTSD symptoms sleep quality and overall quality of life. When the control group subsequently received HBOT they experienced similar benefits reinforcing HBOT’s potential effectiveness. These significant improvements persisted for at least two months post-treatment suggesting that HBOT could offer a lasting solution for individuals struggling with the effects of mTBI.

Results

Hyperbaric Oxygen Therapy (HBOT) significantly improved symptoms and cognitive functions in individuals with persistent post-concussion syndrome (PPCS) following mild traumatic brain injury (mTBI). The study involved 63 participants both civilians and military personnel who were divided into two groups: one receiving HBOT and the other serving as a control group. The HBOT group undertook 40 sessions each lasting 60 minutes at a pressure of 150 kPa.

Key improvements were observed in the treatment group across several domains including neurobehavioral symptoms memory cognitive performance depression anxiety PTSD symptoms sleep quality and overall quality of life. These were measured using standardized tools such as the Neurobehavioral Symptom Inventory Memory Index Automated Neuropsychological Assessment Metrics Hamilton Depression Scale Hamilton Anxiety Scale PTSD Checklist Pittsburgh Sleep Quality Index and the Quality of Life after Brain Injury scale.

Participants who received HBOT showed significant reductions in neurobehavioral symptoms depression anxiety and PTSD symptoms. Additionally there were notable enhancements in memory cognitive performance sleep quality and overall quality of life. The control group which initially did not receive treatment also experienced significant improvements once they underwent the HBOT sessions later on.

Crucially these benefits persisted for at least two months post-treatment signifying the lasting effectiveness of HBOT for individuals with PPCS. The consistent results across both the initial and subsequent treatments in the control group reinforce the potential of HBOT as a reliable therapeutic intervention.

Overall the findings demonstrate that HBOT can serve as a highly effective treatment modality for alleviating symptoms of PPCS and enhancing cognitive and emotional well-being. The significant sustained improvements highlight HBOT as a promising solution for individuals suffering from the long-term effects of mTBI.

Conclusion

In conclusion this study underscores the considerable potential of hyperbaric oxygen therapy (HBOT) for treating persistent post-concussion syndrome (PPCS) resulting from mild traumatic brain injury (mTBI). The research demonstrated that 40 sessions of HBOT at 150 kPa for 60 minutes each yielded significant improvements across a spectrum of symptoms including neurobehavioral cognitive functions depression anxiety PTSD sleep quality and overall quality of life. Remarkably these benefits were evident in both the treatment group and the control group after receiving HBOT and they persisted for at least two months post-treatment. These findings suggest that HBOT can offer lasting relief and improve the quality of life for individuals suffering from PPCS whether civilian or military. Moving forward these compelling results warrant further investigation into HBOT’s broader applicability and mechanisms of action potentially informing new guidelines for the treatment of PPCS and related conditions.